Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...

Insulet (Nasdaq:PODD) today announced its plans to recognize National Diabetes Awareness Month and World Diabetes Day.

The global injection pen market is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2033. The market is expected to escalate ...

Needham analyst Michael Matson has maintained their neutral stance on MDT stock, giving a Hold rating today. Michael Matson’s rating is ...

Medtronic began proactively notifying impacted pump users in July because of the high priority we place on patient safety and understand the important role of pumps in the care and management of ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...

This announcement comes during continued weak performance from Medtronic’s diabetes care division. The company identified a defect relating to battery life and pumps being dropped or hit ...

Secondly, Medtronic's growth areas, including diabetes, electrophysiology, and surgical robotics, are seen as well-positioned for upside, with numerous new products and innovations in the pipeline.

Medtronic Diabetes’ chief medical officer, said in a statement, adding that pumps would be replaced as needed. “Our team is here 24 hours a day, 7 days a week to help if you experience battery ...

Medtronic began proactively notifying impacted pump users in July because of the high priority we place on patient safety and understand the important role of pumps in the care and management of ...

Medtronic has notified customers that battery issues with its Minimed 600 and 700 series insulin pumps could cause the devices to stop delivering insulin significantly sooner than expected. A “low ...